Edwards Lifesciences Corp — Director's Dealing 2021

May 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edwards Lifesciences Corp (EW)
CIK: 0001099800
Period of Report: 2021-05-07

Reporting Person: Szyman Catherine M. (CVP, Critical Care)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-07	Common Stock	M	3389.0000	$22.2867	Acquired	34329.2148	Direct
2021-05-07	Common Stock	S	3389.0000	$91.8700	Disposed	30940.2148	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-07	Employee Stock Option (Right to Acquire)	$22.2867	M	3389.0000	Disposed	2022-02-18	Common Stock (3389.0000)	Direct

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2020.